Search results
Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro
Zacks via Yahoo Finance· 6 hours agoThe FDA approves Bristol Myers' (BMY) cancer drug Augtyro for the treatment of adult and pediatric...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks via Yahoo Finance· 11 hours agoThe FDA approved AstraZeneca’s AZN type-II diabetes (T2D) medicine, Farxiga, for pediatric...
Supreme Court Rejects Challenge to FDA Approval of Mifepristone on Standing, but the Battle...
The National Law Review· 3 hours agoOn June 13, 2024, a unanimous Supreme Court held that physicians and medical associations opposed to...
Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab (Revised)
Zacks via Yahoo Finance· 9 hours agoIf Eli Lilly's (LLY) donanemab is approved by the FDA, it will become the second drug approved by...
Opinion | Trump just dodged a major Supreme Court ruling — for now
MSNBC via Yahoo News· 1 hour agoThe first case began when the Alliance Defending Freedom, a leading litigator in the conservative...
FDA approves imetelstat for some patients with mye | Newswise
Newswise· 3 days agoThe U.S. Food and Drug Administration has approved imetelstat (RYTELO) for the treatment of certain...
The Supreme Court's ruling on mifepristone isn't the last word on the abortion pill
Associated Press via AOL· 4 hours agoThe Supreme Court 's ruling on technical grounds Thursday keeps the abortion pill mifepristone...
The FDA Should Reject MDMA Therapy—but Not for the Reasons You Think
Slate· 1 day agoThe FDA will officially vote Aug. 11 on whether to approve the treatment. The agency isn’t required...
FDA approves two new Abbott over-the-counter continuous glucose monitors
CNBC· 4 days agoAbbott Laboratories announced on Monday it received approval from the U.S. Food and Drug...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 1 day agoThis is appealing to people who are uneasy with the newer mRNA technology. But the competitor...